Correction to article on growth in 'branded generics'
24 10월 2017 - 12:26AM
Dow Jones News
Todd Chermak is Abbott's head of innovation and development for
emerging markets. "Drug Makers Find 'Branded Generics' Are a Source
for Growth" at 8:10 ET, incorrectly spelled his surname as Chermark
in the 24th paragraph. (Oct. 23)
(END) Dow Jones Newswires
October 23, 2017 11:11 ET (15:11 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Hikma Pharmaceuticals (PK) (USOTC:HKMPY)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Hikma Pharmaceuticals plc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Hikma Pharmaceuticals Plc. (PC) News Articles